MedPath

CYTARABINE INJECTION

CYTARABINE INJECTION

Approved
DIN Number

02515296

Drug Class

Human

Market Date

Apr 21, 2022

Company
HC

Sterimax Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02515296
AIG Number0108854005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01BC01 CYTARABINE
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous ,  Intrathecal ,  Intravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

CYTARABINEActive
Strength: 100 MG / ML
Monograph: CYTARABINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.